MannKind Corporation (MNKD) Estados Financieros e Histórico

MannKind Corporation (MNKD) — Precio $3.55 HealthcareBiotechnology — NASDAQ

Últimos resultados publicados:

Estados financieros detallados de MannKind Corporation (MNKD): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.

Resumen del Análisis

MannKind Corporation registró ingresos de $349.0M en el último ejercicio fiscal, con un CAGR de 5 años del 39.9%.

Márgenes de los últimos 12 meses: margen bruto 75.7%, margen operativo 2.0%, margen neto -11.1%.

Al precio actual de $3.55, MNKD presenta beneficios negativos (P/E no significativo) y un ROE del 78.60%. La capitalización bursátil es de $1.1B.

Cuenta de Resultados (10 años)

Año2016201720182019202020212022202320242025
Ingresos$174.8M$11.7M$27.9M$63.0M$65.1M$75.4M$99.8M$199.0M$285.5M$349.0M
Coste de Ventas$50.1M$17.2M$20.5M$28.0M$24.6M$38.9M$57.5M$62.8M$76.6M$61.2M
Beneficio Bruto$124.7M-$5.5M$7.4M$35.1M$40.5M$36.6M$42.3M$136.2M$208.9M$287.8M
I+D$14.9M$14.1M$8.7M$6.9M$6.2M$12.3M$19.7M$31.3M$45.9M$66.3M
Generales y Administrativos$46.9M$75.0M$79.7M$74.7M$59.0M$77.4M$91.5M$94.3M$94.3M$144.1M
Gastos Operativos$59.6M$88.9M$88.4M$79.7M$88.4M$83.6M$106.4M$127.5M$136.3M$249.0M
Beneficio Operativo$67.3M-$108.2M-$76.6M-$44.6M-$47.9M-$47.0M-$64.1M$8.7M$72.6M$38.8M
EBITDA$146.5M-$102.2M-$75.6M-$38.8M-$44.7M-$61.1M-$56.3M$15.1M$77.5M$27.5M
Gastos por Intereses$18.5M$13.3M$9.4M$10.9M$9.5M$16.6M$24.8M$25.2M$38.0M$13.8M
Beneficio Antes de Impuestos$125.7M-$117.3M-$86.7M-$51.9M-$57.5M-$80.9M-$87.4M-$10.4M$30.5M$1.4M
Impuestos0$51000$2400000-$21800000$1.6M$2.9M-$4.5M
Beneficio Neto$125.7M-$117.3M-$87.0M-$51.9M-$57.2M-$80.9M-$87.4M-$11.9M$27.6M$5.9M
BPA$1.37$-1.13$-0.60$-0.31$-0.26$-0.37$-0.44$-0.04$0.10$0.02
BPA Diluido$1.36$-1.13$-0.60$-0.31$-0.26$-0.37$-0.44$-0.04$0.10$0.02
Acciones en Circulación (Diluidas)$92.1M$104.2M$144.1M$195.6M$222.6M$249.2M$257.1M$267.0M$283.8M$314.1M

Cuenta de Resultados (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Ingresos$82.1M$112.0M$90.2M$109.4M
Beneficio Bruto$61.9M$87.8M$68.3M$79.8M
Beneficio Operativo$18.8M-$7.7M-$3.0M-$350000
EBITDA$17.9M-$2.5M$2.5M$12.9M
Beneficio Neto$8.0M-$15.9M-$16.6M-$19.0M
BPA$0.03$-0.05$-0.05$-0.06
BPA Diluido$0.03$-0.05$-0.05$-0.06

Balance (10 años)

Año2016201720182019202020212022202320242025
Caja y Equivalentes$22.9M$43.9M$71.2M$29.9M$67.0M$124.2M$69.8M$238.5M$46.3M$74.9M
Inversiones a Corto000$20.0M0$79.9M$101.1M$56.6M$150.9M$96.5M
Cuentas por Cobrar$30.9M$2.8M$4.0M$3.5M$4.2M$4.7M$16.8M$14.9M$11.8M$38.4M
Inventario$2.3M$2.7M$3.6M$4.2M$5.0M$7.2M$21.8M$28.5M$27.9M$35.3M
Activos Corrientes$77.5M$57.2M$81.9M$60.8M$79.5M$219.5M$234.9M$373.4M$268.3M$291.6M
Inmovilizado Material$28.9M$26.9M$25.6M$26.8M$25.9M$36.6M$45.1M$84.2M$85.4M$82.4M
Fondo de Comercio000000$2.4M$1.9M$1.9M$67.6M
Activos Intangibles000000$1.2M$1.1M$5.3M$5.1M
Activos Totales$107.1M$84.6M$107.7M$93.7M$108.6M$321.2M$295.3M$475.2M$393.8M$792.2M
Cuentas por Pagar$3.3M$7.0M$5.4M$4.8M$5.6M$7.0M$11.1M$9.6M$6.8M$9.0M
Deuda a Corto$71.3M$52.7M$11.3M$5.0M$4.1M$7.0M$9.6M$20.0M0$49.2M
Pasivos Corrientes$92.1M$87.6M$75.2M$65.6M$73.7M$48.3M$67.3M$104.1M$81.8M$171.0M
Deuda a Largo$77.2M$104.1M$91.2M$113.9M$118.2M$281.2M$273.5M$248.7M$36.1M$320.4M
Pasivos Totales$290.7M$299.3M$282.8M$284.3M$289.0M$530.5M$545.8M$721.4M$472.7M$843.2M
Reservas-$2.74B-$2.85B-$2.94B-$2.99B-$3.05B-$3.13B-$3.22B-$3.23B-$3.20B-$3.20B
Patrimonio Neto-$183.6M-$214.7M-$175.1M-$190.5M-$180.4M-$209.3M-$250.5M-$246.2M-$78.8M-$51.0M
Deuda Total$148.5M$156.8M$102.5M$121.4M$123.4M$289.2M$288.4M$272.6M$47.7M$473.4M
Deuda Neta$125.6M$112.9M$31.3M$71.5M$56.4M$85.1M$117.6M-$22.5M-$149.6M$302.0M
Capital Circulante-$14.6M-$30.4M$6.6M-$4.9M$5.8M$171.1M$167.6M$269.3M$186.5M$120.5M

Balance (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Caja y Equivalentes$127.4M$74.9M$52.8M$52.9M
Activos Totales$494.6M$792.2M$744.4M$732.3M
Pasivos Totales$539.2M$843.2M$803.6M$799.5M
Patrimonio Neto-$44.6M-$51.0M-$59.2M-$67.2M
Deuda Total$226.0M$473.4M$436.7M$330.8M

Flujo de Caja (10 años)

Año2016201720182019202020212022202320242025
Beneficio Neto$125.7M-$117.3M-$87.0M-$51.9M-$57.2M-$80.9M-$87.4M-$11.9M$27.6M$5.9M
Amortizaciones$4.2M$3.5M$1.7M$2.2M$3.3M$5.5M$6.3M$5.8M$9.0M$12.3M
Compensación en Acciones$5.1M$4.8M$6.9M$6.2M$6.5M$12.2M0$17.6M$21.4M$24.2M
Cambio en Capital Circulante-$139.3M$27.6M$36.7M-$12.4M-$9.8M-$17.7M-$24.1M$14.6M-$36.5M-$86.3M
Flujo de Caja Operativo-$78.1M-$64.8M-$37.7M-$88.5M-$28.1M-$61.7M-$80.7M$34.1M$42.5M$18.3M
Inversiones (CapEx)-$1.1M0-$354000-$2.6M-$4.8M-$11.5M-$7.6M-$42.4M-$9.7M-$4.6M
Adquisiciones$17000$24000$1200000-$4.0M-$56.1M-$15.3M00-$347.7M
Recompra de Acciones000000000-$3.3M
Dividendos Pagados0000000000
Flujo de Caja Libre-$79.2M-$64.8M-$38.1M-$91.0M-$32.9M-$73.2M-$88.3M-$8.3M$32.8M$13.7M

Flujo de Caja (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Flujo de Caja Operativo$23.5M-$8.0M-$5.6M-$18.4M
Inversiones (CapEx)-$1.1M-$2.0M-$1.9M-$5.1M
Flujo de Caja Libre$22.4M-$10.0M-$7.5M-$23.5M
Dividendos Pagados0000
Compensación en Acciones0$7.0M0$10.2M

Crecimiento y Márgenes (10 años)

Año2016201720182019202020212022202320242025
Crecimiento Ingresos (anual)-93.3%+137.2%+126.3%+3.3%+15.8%+32.2%+99.4%+43.5%+22.2%
Crecimiento Beneficio Neto (anual)-193.4%+25.9%+40.3%-10.3%-41.4%-8.0%+86.3%+331.1%-78.7%
Crecimiento BPA (anual)-182.5%+46.9%+48.3%+16.1%-42.3%-18.9%+89.8%+323.7%-80.0%
Cambio en Acciones (anual)+13.2%+38.3%+35.7%+13.8%+12.0%+3.1%+3.9%+6.3%+10.7%
Crecimiento FCF (anual)+18.2%+41.2%-139.1%+63.9%-122.3%-20.7%+90.5%+493.2%-58.3%
Margen Bruto71.3%-46.7%26.5%55.6%62.2%48.5%42.4%68.5%73.2%82.5%
Margen Operativo38.5%-921.1%-274.9%-70.7%-73.5%-62.3%-64.3%4.4%25.4%11.1%
Margen EBITDA83.9%-870.2%-271.4%-61.6%-68.6%-81.0%-56.4%7.6%27.1%7.9%
Margen Neto71.9%-999.0%-312.2%-82.3%-87.9%-107.3%-87.6%-6.0%9.7%1.7%
Margen FCF-45.3%-551.5%-136.7%-144.4%-50.5%-97.0%-88.5%-4.2%11.5%3.9%
Tasa Impositiva Efectiva0.0%-0.0%-0.3%-0.0%0.4%-0.0%-0.0%-15.0%9.6%-316.7%

Datos por Acción (10 años)

Año2016201720182019202020212022202320242025
FCF por Acción$-0.86$-0.62$-0.26$-0.47$-0.15$-0.29$-0.34$-0.03$0.12$0.04
Dividendo por Acción$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Acciones en Circulación (Básicas)$92.1M$103.8M$144.1M$195.6M$222.6M$249.2M$257.1M$267.0M$274.4M$305.6M

Qué mirar en Biotech

La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.

Rentabilidad

Rentabilidad sobre capital78.60%
Rentabilidad sobre capital invertido1.18%
Rentabilidad sobre activos-5.96%
Margen bruto75.69%
Margen operativo1.97%
Margen neto-11.08%

Salud financiera

Deuda / Patrimonio-4.92
Ratio corriente1.72

Ratios Clave (10 años)

Año2016201720182019202020212022202320242025
P/E2.32-2.05-1.77-4.16-12.04-11.81-11.98-81.4364.30283.50
P/VC-1.60-1.12-0.87-1.32-3.86-5.20-5.41-3.95-22.39-33.97
P/V1.6820.515.484.0010.6914.4413.584.896.184.97
Margen Bruto71.3%-46.7%26.5%55.6%62.2%48.5%42.4%68.5%73.2%82.5%
Margen Operativo38.5%-921.1%-274.9%-70.7%-73.5%-62.3%-64.3%4.4%25.4%11.1%
Margen Neto71.9%-999.0%-312.2%-82.3%-87.9%-107.3%-87.6%-6.0%9.7%1.7%

Empresas relacionadas: ABCL · AUPH · BHVN · CLDX · HRMY · IMCR · JANX

Explorar sector: Healthcare · Biotechnology

Más secciones de MNKD: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos

Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones